IP Library Granted Patent US 8,841,438
Granted Patent B2
US 8,841,438 · App. 13/321,816 · Granted Sep 23, 2014

Trans-acting RNA switches

Inventors: Scott A. Tenenbaum (Selkirk, NY); Francis J. Doyle, II (Albany, NY); Ajish George (Timonium, MD); Christopher Zaleski (Huntington, NY)
Assignee: The Research Foundation of the University of New York
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,841,438
App. No.
13/321,816
Granted
Sep 23, 2014
Kind
B2
Abstract

Disclosed are RNA constructs which function to activate or inactivate a biological process, e.g., may be designed for attachment to a polypeptide coding region. Such RNA constructs modulate translation of a polypeptide from the coding region in response to the presence of a target polynucleotide in an expression environment. Such RNA constructs include a weakened stem-loop structure which, when bound to the target polynucleotide, assumes stem-loop secondary structure and associates with an RNA binding protein. Association with the RNA binding protein modulates translation of the polypeptide coding region. Such RNA constructs also have three-way junction joining regions 3′ and 5′ of the stem-loop structure.

Claims (25)

1. An RNA construct comprising a non-naturally occurring, continuous sequence of ribonucleotide bases defining:

a stem-loop structure;

simulated, three way junction joining regions 3′ and 5′ of the stem-loop structure;

a first region 5′ of the 5′ joining region comprising bases complementary to a 3′ region of a target polynucleotide, wherein the target polynucleotide is not continuous with the RNA construct;

a second region 3′ of the 3′ joining region comprising bases complementary to a 5′ region of the target polynucleotide;

the base sequence of the first and second regions being selected to base pair with complementary bases on the target polynucleotide spaced apart by an intermediate region on the target polynucleotide defining another three way junction joining region, whereby,

in the presence of the target polynucleotide, a stem-loop conformation of said construct is stabilized.

2. The construct of claim 1 , wherein at least one base in the stem of the stem-loop structure is mismatched with its potential binding partner so as to reduce the stability of the stem-loop conformation.

3. The construct of claim 1 wherein the RNA construct further comprises RNA defining a polypeptide coding region and wherein

in the absence of the target polynucleotide, the construct assumes a conformation inhibiting association with an RNA binding protein and suppressing translation of the polypeptide-coding region, and

in the presence of the target polynucleotide, the construct assumes a stem-loop conformation promoting association with the RNA binding protein and promoting translation of the polypeptide coding region.

4. The construct of claim 3 wherein the polypeptide coding region is disposed 5′ of the first region.

5. The construct of claim 1 , wherein the target polynucleotide is characteristic of a pathogen.

6. The construct of claim 5 wherein the pathogen is a virus or a single-celled microorganism.

7. The construct of claim 1 , wherein the target polynucleotide is expressed preferentially in a cell type of a multicellular organism.

8. The construct of claim 7 wherein the cell type is a neoplastic cell.

9. The construct of claim 1 , wherein the target polynucleotide comprises a synthetic target polynucleotide or ssDNA for transfection into a cell.

10. A DNA vector comprising a transcription unit encoding a construct as in claim 1 .

11. A cell comprising a construct as in claim 1 .

12. The construct of claim 1 , wherein a joining region comprises no more than about 10 nucleotides.

13. The construct of claim 3 , wherein the polypeptide coding region encodes a polypeptide needed for survival of a cell whereby only in the presence of the construct and the target polynucleotide in the cell can the cell survive.

14. The construct of claim 3 , wherein the polypeptide coding region is expressed in a cell and encodes a polypeptide lethal to the cell.

15. The construct of claim 14 wherein the cell is an infected cell or a neoplastic cell, and the target polynucleotide is expressed by an organism infecting the cell or by the neoplastic cell.

16. The construct of claim 3 , wherein the polypeptide coding region encodes a detectable marker polypeptide whose detection indicates the presence of an analyte comprising the target polynucleotide.

17. The construct of claim 1 , wherein the construct comprises more than one said stem-loop structure.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2014
From: TENENBAUM, SCOTT A.; DOYLE, FRANCIS J., II; GEORGE, AJISH; ZALESKI, CHRISTOPHER
To: THE RESEARCH FOUNDATION OF THE UNIVERSITY OF NEW YORK
Reel/Frame 032508/0787 →
CONFIRMATORY LICENSE Recorded Dec 12, 2013
From: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031805/0650 →
Continuity (2)
Provisional Application 61180670 · May 22, 2009
Related Publication 20120252876A1 · Oct 4, 2012